Trial Profile
Investigation of efficacy and safety of insulin degludec or insulin glargine in type 2 diabetes with basal-bolus therapy
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 04 Nov 2014
Price :
$35
*
At a glance
- Drugs Insulin degludec (Primary) ; Insulin glargine
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions; Therapeutic Use
- Acronyms JUN-SIBA study
- 02 Nov 2014 Status changed from recruiting to discontinued as reported by UMIN record.
- 02 Jul 2014 New trial record